LHYFE — Lhyfe SA Income Statement
0.000.00%
Last trade - 00:00
- €208.17m
- €144.82m
- €1.32m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 8 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.003 | 0.197 | 0.57 | 1.32 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.003 | 0.021 | 0.176 | 0.672 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.379 | 1.3 | 5.88 | 19.7 | 35.7 |
Operating Profit | -0.379 | -1.3 | -5.68 | -19.2 | -34.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.432 | -1.6 | -8.72 | -25.8 | -32.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.432 | -1.6 | -8.72 | -25.8 | -32.8 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.432 | -1.6 | -8.72 | -25.8 | -33.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.432 | -1.6 | -8.72 | -25.8 | -33.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.034 | -0.186 | -0.539 | -0.7 |
Dividends per Share |